ArticleDiscover oncology2025

SGLT2 inhibitors and their role in reducing mortality among cancer patients with type 2 diabetes undergoing immune checkpoint inhibitor therapy.

Fabiana Lucà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.